• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Ocko Matthew sold $26,614,234 worth of shares (1,020,000 units at $26.09) (SEC Form 4)

    6/18/25 1:39:54 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Ocko Matthew

    (Last) (First) (Middle)
    C/O ROCKET LAB CORPORATION
    3881 MCGOWEN STREET

    (Street)
    LONG BEACH CA 90808

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Rocket Lab Corp [ RKLB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/12/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/12/2025 S 57,822 D $26.4437(1) 1,320,121 I See footnote(2)
    Common Stock 06/12/2025 S 142,178 D $26.4437(1) 3,246,071 I See footnote(3)
    Common Stock 06/13/2025 S 237,068 D $26.0067(4) 1,083,053 I See footnote(2)
    Common Stock 06/13/2025 S 582,932 D $26.0067(4) 2,663,139 I See footnote(3)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions at prices ranging from $26.3750 to $26.6300, inclusive. The Reporting Person undertakes to provide to Rocket Lab Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
    2. Represents securities held of record by Data Collective IV, L.P. ("DCVC IV"). Data Collective IV GP, LLC ("DCVC IV GP") is the general partner of DCVC IV and has sole voting and dispositive power with regard to the securities held by DCVC IV. The Reporting Person is a managing member of DCVC IV GP and shares voting and dispositive power with respect to the securities held by DCVC IV. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any.
    3. Represents securities held of record by DCVC Opportunity Fund II, L.P. ("DCVC Opportunity Fund II"). DCVC Opportunity Fund II GP, LLC ("DCVC Opportunity Fund II GP") is the general partner of DCVC Opportunity Fund II and has sole voting and dispositive power with regard to the securities held by DCVC Opportunity Fund II. The Reporting Person is a managing member of DCVC Opportunity Fund II GP and shares voting and dispositive power with respect to the securities held by DCVC Opportunity Fund II. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities, except to the extent of his indirect pecuniary interest therein, if any.
    4. The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 819,184 shares sold at prices ranging from $25.4500 to $26.4400 and 816 shares sold at prices ranging from $26.4600 to $26.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
    /s/ Matthew Ocko 06/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RKLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    7/15/2024$8.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    6/26/2024Neutral
    BTIG Research
    6/11/2024$4.50Neutral
    Goldman
    2/12/2024$6.00Buy
    Citigroup
    1/17/2024$8.00Overweight
    KeyBanc Capital Markets
    10/26/2023$6.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $RKLB
    SEC Filings

    See more
    • SEC Form 144 filed by Rocket Lab Corporation

      144 - Rocket Lab Corp (0001819994) (Subject)

      6/20/25 4:28:05 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 15-12G filed by Rocket Lab Corporation

      15-12G - Rocket Lab Corp (0001819994) (Filer)

      6/9/25 5:09:09 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • SEC Form 144 filed by Rocket Lab Corporation

      144 - Rocket Lab Corp (0001819994) (Subject)

      6/9/25 4:29:54 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ocko Matthew sold $26,614,234 worth of shares (1,020,000 units at $26.09) (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      6/18/25 1:39:54 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • President, CEO and Chairman Beck Peter converted options into 5,000,000 shares (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      6/17/25 7:59:49 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Operations Officer Klein Frank sold $76,380 worth of shares (2,546 units at $30.00), decreasing direct ownership by 0.19% to 1,365,826 units (SEC Form 4)

      4 - Rocket Lab Corp (0001819994) (Issuer)

      6/10/25 7:37:48 PM ET
      $RKLB
      Military/Government/Technical
      Industrials